ResMed (RMD) Revenue — Quarter Ended Jun 30, 2025
Revenue increased in the current quarter compared to the prior quarter. Revenue also rose compared to the same quarter one year earlier.
Key takeaway
Quarter ended Jun 30, 2025 · FY2025 Q4
Revenue increased in the current quarter compared to the prior quarter. Revenue also rose compared to the same quarter one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.3B
Revenue reported for this quarter.
Quarter-over-quarter
+4.4%
Change from the immediately preceding quarter.
Year-over-year
+10.2%
Change from the comparable year-ago quarter.
Trailing four quarters
$5.1B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2024 | $1.2B | +11.1% |
| Dec 31, 2024 | $1.3B | +10.3% |
| Mar 31, 2025 | $1.3B | +7.9% |
| Jun 30, 2025 | $1.3B | +10.2% |
Revenue performance
The reported revenue direction is upward, continuing the positive trend observed in recent quarters.
Quarterly comparison
Compared with the immediately preceding quarter, revenue improved. Versus the same quarter one year earlier, revenue was also higher.
What to watch
The filing notes that cash provided by operating activities may fluctuate due to factors including supply chain disruptions and working capital requirements.